---
title: "Global.health"
subtitle: "Developing a multi-year strategy and product roadmap for a global health initiative"
excerpt: >
  Fenris created a phased, fundable execution plan that translated Global.health's ambitious mission into a strategic product roadmap with a clear path from pilot to durable civic asset.
date: 2022-01-01
author: Aman Ahuja
images:
    - /images/logos/gh-logo-alt.png
tags:
    - civil-society
    - product
    - lifesciences
    - epidemiology
series:
    - "Fenris"
categories: 
    - "Projects"
layout: single-sidebar
draft: false
---

Fenris worked with the Global.health leadership team to develop a multi-year strategy and product roadmap that translated their global mission into phased, fundable execution steps.

Our team helped G.h leaders refine a vision through a series of workshops. With the product team, we co-developed programs and objectives that were consistent with this vision and with constraints. The sequencing was carefully designed based on data readiness, governance requirements, and operating capacity of the organization.

Inviting input from advisors and stakeholders, we created a *strategic product roadmap* with a three-year horizon that served as both an alignment tool and an investment signal for funders. This roadmap demonstrated Fenris's experience in developing a credible path from pilot project to durable civic asset.

These assets were developed over a 17-week engagement to be carried forward by product leads starting in 2022.

Additional support was provided through: 
* Product management and support of the engineering and development team
* Development of assets and training for user research as part of the G.h product development life-cycle
* Recommendations on engineering process and resourcing

### About Global.health

![Global.health logo](/images/logos/gh-logo-alt.png)

Global.health ([https://global.health](https://global.health/))

> Global.health is a data repository and visualization platform that enables open access to real-time epidemiological anonymized line-list data. The product was created by a collaboration of institutions including Oxford, Harvard, Northeastern, Boston Childrenâ€™s Hospital, Georgetown, University of Washington, and Johns Hopkins Center for Health Security.

